Is the 2009 H1N1 Swine Flu Vaccine Safe? An Update

How many uninsured people need additional help from taxpayers?
September 15, 2009
Experts recommend N95 masks over surgical masks to stop spread of H1N1
September 16, 2009
Show all

Is the 2009 H1N1 Swine Flu Vaccine Safe? An Update

I’m getting tons of emails and questions at the practice about the safety of the Swine flu vaccine (the Swine flu is now officially called the “2009 H1N1 influenza). Will it be safe? Will it cause cancer? Will it contain preservatives or adjuvants? One friend wrote: Are you taking it? Are you recommending it to your family. Here are my answers and the latest update:
I wrote my friend, “Yes, on both counts. I’m planning to take it. And, I’m recommending it for my family — especially my son Scott, his pregnant wife, Jennifer, and their child, Anna Kate. In fact, the only protection Sarah Elisabeth (who will be born in November) will have against the influenza is the “cocoon of protection” offered by an immunized family.
This update, just out from the CDC, will give you the information you need.
Q: Will the 2009 H1N1 influenza vaccines be safe?
We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have a very good safety track record. Over the years, hundreds of millions of Americans have received seasonal flu vaccines. The most common side effects following flu vaccinations are mild, such as soreness, redness, tenderness or swelling where the shot was given.
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) will be closely monitoring for any signs that the vaccine is causing unexpected adverse events and we will work with state and local health officials to investigate any unusual events.
Q: Are there any side effects to the 2009 H1N1 influenza vaccine?
CDC expects that any side effects following vaccination with the 2009 H1N1 influenza vaccine would be rare. If side effects occur, they will likely be similar to those experienced following seasonal influenza vaccine.
Mild problems that may be experienced include soreness, redness, or swelling where the shot was given, fainting (mainly adolescents), headache, muscle aches, fever, and nausea.  If these problems occur, they usually begin soon after the shot and last 1-2 days. Life-threatening allergic reactions to vaccines are very rare. If they do occur, it is usually within a few minutes to a few hours after the shot is given.
If you have a side effect, ask your doctor, nurse, or health department to report the reaction by filing a Vaccine Adverse Event Reporting System (VAERS) form. Or you can file this report yourself through the VAERS Web site here. You may also call 1-800-822-7967 to receive a copy of the VAERS form.
Q: Are there some people who should not receive this vaccine?
People who have a severe (life-threatening) allergy to chicken eggs or to any other substance in the vaccine should not be vaccinated.
Q: How will the 2009 H1N1 influenza vaccines be monitored for safety?
The CDC and FDA closely monitor the safety of seasonal influenza and other vaccines licensed for use in the United States in cooperation with state and local health departments, healthcare providers, and other partners.
Q: Will the 2009 H1N1 vaccines that are currently recommended contain adjuvants?
No. According to current federal plans, only unadjuvanted vaccines will be used in the United States during the 2009 flu season. This includes all of the 2009 H1N1 and seasonal influenza vaccines that will be available for children and adults in both the injectable and nasal spray formulations. None of these influenza vaccines will contain adjuvants.
Q: Will the 2009 H1N1 influenza vaccine contain thimerosal?
The 2009 H1N1 influenza vaccines that FDA is licensing (approving) will be manufactured in several formulations.
SOME WILL come in multi-dose vials and will contain thimerosal as a preservative. Multi-dose vials of seasonal influenza vaccine WILL contain thimerosal to prevent potential contamination after the vial is opened.
However, SOME 2009 H1N1 influenza vaccines will be available in single-dose units, which will NOT contain thimerosal as a preservative.
In addition, the live-attenuated version of the vaccine, which is administered intranasally (through the nose), is produced in single-units and will NOT contain thimerosal. For more information on thimerosal click here.
Also, see my previous blogs on thimerosal:

Q: Will the benefits of the 2009 H1N1 influenza vaccines outweigh the risks? Is this something I should talk to my healthcare provider about?
Currently the 2009 H1N1 influenza virus (sometimes called “swine flu”) virus seems to be causing serious health outcomes for:

  • healthy young people from birth through age 24;
  • pregnant women; and
  • adults 25 to 64 who have underlying medical conditions.

Seasonal influenza vaccines are highly effective in preventing influenza disease. The expectation is that a vaccine against 2009 H1N1 influenza would probably work in a similar fashion to the seasonal influenza vaccines. CDC and FDA believe that the benefits of vaccination with the 2009 H1N1 influenza vaccine will far outweigh the risks.
Vaccination is the best way to prevent influenza infection and its complications. This is the reason that CDC, national health organizations, and healthcare providers intensively promote vaccination for seasonal influenza, and the reason why so much work is being done to have a vaccine available in the fall for the 2009 H1N1 influenza virus.
Influenza vaccines do not protect against other viruses that cause respiratory illnesses. Even after you are vaccinated, it is still important to wash your hands well and often, to cover your coughs and sneezes, and to stay home if you are sick.
CDC and FDA encourage you to ask your healthcare provider any questions you may have about the 2009 H1N1 influenza vaccine and the seasonal influenza vaccines that will be available during the 2009-2010 influenza season. Your healthcare provider is an excellent source for information on the benefits and risks of vaccination for protection against 2009 H1N1 influenza for you, your children, and other family members.
Q: Will there be a possibility of Guillain-Barré Syndrome (GBS) cases following the 2009 H1N1 vaccine?
Guillain-Barré syndrome (GBS) is a rare disease in which the body damages its own nerve cells, causing muscle weakness and sometimes paralysis. It is not fully understood why some people develop GBS, but it is believed that stimulation of the body’s immune system may play a role in its development.
In 1976, there was a small risk of GBS following influenza (swine flu) vaccination (approximately 1 additional case per 100,000 people who received the swine flu vaccine). That number of GBS cases was slightly higher than what is normally seen in the population, whether or not people were vaccinated.
Since then, numerous studies have been done to evaluate if other flu vaccines were associated with GBS. In most studies, no association was found, but two studies suggested that approximately 1 additional person out of 1 million vaccinated people may be at risk for GBS associated with the seasonal influenza vaccine. FDA and CDC will be closely monitoring reports of serious problems following the 2009 H1N1 influenza vaccines, including GBS.
You can read more about GBS and vaccines here.
Q: What is the best source of information for 2009 H1N1 influenza vaccine safety?
In addition to talking openly with your healthcare providers, CDC also encourages you to stay informed by checking the following Web sites often for the most up-to-date news and information

Here are some of my previous posts on the topic:

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.